ASPG and T-cell non-Hodgkin lymphoma: The efficacy and safety of another L-asparaginase-containing regimen GELOX (gemcitabine, L-asparaginase, and oxaloplatin) together with sandwich radiotherapy was examined in 27 patients with stage I/II NK/T-cell lymphoma [71].